TF and neoplasm: We apply and experimentally test SPaRTAN using CITE-seq datasets from peripheral blood mononuclear cells (PBMCs) and then illustrate its broader utility by predicting signaling coupled TF activities in tumor infiltrating CD8+ T cells in the context of malignant peritoneal and pleural mesothelioma.